Given small data sets suggesting a potential increase in procaspase-3 levels in malignant brain tumors in comparison to benign tumors and normal brain tissue [14], a comprehensive retrospective survey was performed to determine if increased CASP3 (encoding procaspase-3) expression affected prognosis in glioblastoma. This evidence concerns the gene CASP3 and benign neoplasm.